Apr 29,2014

‘SmartQuit’ smoking cessation app lands $250k grant, exclusive Fred Hutch license

A smartphone app called “SmartQuit,” proven in clinical studies to help people stop smoking, will be brought to market after landing a $250,000 grant from the Washington Life Sciences Discovery Fund, and reaching an exclusive licensing agreement with the Fred Hutchinson Cancer Research Center in Seattle. The agreement was announced this morning, and the app is slated to be available by late 2014. The SmartQuit app, developed by Seattle startup 2Morrow Inc., is based on research by Jonathan Bricker, PhD., who works in the Public Health Sciences Division at Fred Hutch and led the first randomized, controlled trial comparing the effectiveness of smoking cessation apps. SmartQuit uses “acceptance and commitment therapy,” or ACT, in which people are helped to accept their urges and let them pass.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Aug 29,2014

Orexo raises $50.6 million

Orexo AB (SSE:ORX; OTCQX:ORXOY) raised SEK346.5 million ($50.6 million) through the sale of 2.5 million shares at SEK139 in a private placement. The company sold 1.1 million treasury shares and issued 1.4 million new shares. Danske Bank is the sole lead manager and bookrunner.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Sep 10,2014

Glen Tullman Launches Livongo Health™ to Empower Consumers with Chronic Conditions to Live Better, Beginning with Diabetes

Livongo Health™, a consumer digital health company, launched today with a vision to empower people with chronic conditions to live better through the combined power of technology, real-time personalized information, and support from their chosen care team. The company secured initial funding from 7wire Ventures (run by Tullman and long-time partner Lee Shapiro) and a recent $10 million Series A funding round from General Catalyst Partners.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Oct 13,2014

Hello Doctor gets $700K for its personal medical records app

The Tel Aviv and Palo Alto, Calif.-based company says it has picked up $700K in new funding from some angel investors from Facebook, Google, and a couple of pharma companies. Hello Doctor CEO Maayan Cohen said the investors preferred to remain unnamed for the moment. It’s previously taken funding from BlueRun Ventures. The app can also now interface with about half of U.S. hospitals.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 28,2014

Vida raises $5 million for app-based health and wellness coaching

San Francisco-based mobile-enabled health coaching services company Vida has raised $5 million in its first round of funding from Aspect Ventures, Khosla Ventures, Yahoo Co-Founder Jerry Yang, Signia Venture Partners, The Valley Fund, Yahoo Chairman Maynard Webb, Silicon Valley Bank's Kevin Scott, and Skip Battle. The company also commercially launched its app direct-to-consumer health and wellness coaching services, which cost $15 a week. Vida connects its users to nutritionists, physicians, diabetes educators, nurses, and more via its iPhone app. Vida CEO and Founder Stephanie Tilenius told MobiHealthNews the company also plans to develop an Android app for its service in the future.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 11,2015

MediSafe Raises $6M In Series A Funding

According to a “Geektime” report, the Israeli mobile medication management company MediSafe , raised $6 million in Series A funding. The report outlines that Pitango Ventures and well as TriVentures participated in the round, which brings the total amount raised by the company to over $7 million. “Geektime” also reports that MediSafe rejected a $25 million acquisition offer earlier last year made by an unnamed medical data company.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Feb 23,2015

Welldoc raises $4.2 Million

The document is a Form D filing submitted to the U.S. Securities and Exchange Commission (SEC) by WellDoc, a digital health company that provides personalized, evidence-based solutions for individuals with chronic conditions. The purpose of the filing is to disclose that WellDoc has raised $4,230,062 in equity financing. The funds will be used to support the company's growth and expansion efforts.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Feb 25,2015

LabStyle Innovations Raises $1.6 Million in a Non-Brokered Private Placement Financing

LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced that it raised $1.6 million in a private placement offering consisting of shares of common stock and warrants. No placement agent was used for this financing. LabStyle intends to use the net proceeds from the offering to fund continuing manufacturing and sales efforts in existing and new markets and to continue ongoing regulatory work associated with its pending FDA 510(k) application for Dario™, as well as for general working capital.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Mar 04,2015

MindMaze lands $8.5 million funding round

Switzerland-based MindMaze announced this week that it recently closed an $8.5 million round of funding to bring its MindLeap system, previously used to help stroke patients recover some motor function, to the world of games. Investors were not disclosed. MindLeap is in development for multiple platforms, including consoles and mobile devices. The company plans to have a software development kit available in the coming months, with a proper release set for late this year.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Mar 11,2015

Digital Health Startup mySugr Gets $4.8M To Make Diabetes “Suck Less”

mySugr is announcing a new seed funding raise — of $4.8 million from two new investors, Switzerland-based Roche Ventures and U.S.-based iSeed Ventures. Existing investor XLHealth, from Germany, also participated in the round. Total funding raised to date is around $5.8 million. What’s the new cash injection for? Serious scale — as befits the team’s missionary zeal to help more diabetes sufferers like themselves.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING